{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:54:24Z","timestamp":1792457664597,"version":"4.5.0"},"reference-count":57,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Lab Hematology"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>The direct thrombin inhibitor argatroban is licensed for use in Heparin\u2010induced thrombocytopenia. Original trial data gave the recommendation of monitoring argatroban by Activated Partial Thromboplastin Time (APTT) stating a therapeutic target range of 1.5\u20133.0 times baseline APTT and not exceeding 100\u2009s. APTT has limitations due to prolongation arising in factor deficiencies, lupus anticoagulants, liver disease, and high FVIII levels leading to potential overestimation of argatroban. Argatroban has demonstrated a plateau effect on APTT at higher concentrations; additionally, APTT reagents have different sensitivity to argatroban, potentially underestimating or overestimating the argatroban. Anti\u2010IIa methods have been recommended as a suitable alternative to accurately quantify argatroban levels. However, there is a lack of consensus on what the target therapeutic range should be. This review will demonstrate how argatroban monitoring by APTT may not be the most suitable method to successfully dose argatroban based on the current state of knowledge and recent published guidelines and highlight the benefits of the anti\u2010IIa methods.<\/jats:p>","DOI":"10.1111\/ijlh.70103","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:03:57Z","timestamp":1777950237000},"page":"737-746","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Review of the Current Issues Surrounding Monitoring of the Direct Thrombin Inhibitor Argatroban in the Laboratory"],"prefix":"10.1111","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4904-0655","authenticated-orcid":false,"given":"Susan","family":"Guy","sequence":"first","affiliation":[{"name":"Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital  Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4203-299X","authenticated-orcid":false,"given":"Kieron","family":"Hickey","sequence":"additional","affiliation":[{"name":"Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital  Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhona","family":"Maclean","sequence":"additional","affiliation":[{"name":"Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital  Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0076\u20106879(93)22022\u20108"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/009127009903900512"},{"key":"e_1_2_9_4_1","volume-title":"Prescribing Information for Argatroban","year":"2009"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.103.14.1838"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.15.1849"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.20.9.756.35194"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199105303242206"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.14488"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0b013e3282fe73ec"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH06-10-0607"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPQOD9WFPEYY0H"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/0897190019885232"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1R745"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/10760296211066945"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000903S"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/1076029617699087"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH16\u201006\u20100468"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000200122"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1055\/s\u20100036\u20101597297"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1055\/s\u20102002\u201034305"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1309\/Q0G21Y26UR0UHQ1A"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2020.03.012"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18120"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mbc.0000169217.15926.d0"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.90.4.1624"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1055\/s\u20100037\u20101603356"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21916"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D565"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538\u20107836.2005.01577.x"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13165"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12414"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2012.02.041"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11239\u2010019\u201001961\u20103"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/aln.0000000000004787"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1309\/ajcpgtcex7k4gxqo"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14397"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12871\u2010018\u20100475\u2010y"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2025.08.065"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2011.11.041"},{"issue":"2","key":"e_1_2_9_41_1","first-page":"37","article-title":"Practical Guidelines for Argatroban and Bivalirudine in Patients With Heparin\u2010Induced Thrombocytopenia","volume":"1","author":"Colucci G.","year":"2015","journal-title":"Journal of Clinical and Translational Science"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1274516"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19729"},{"key":"e_1_2_9_44_1","unstructured":"Lepirudin Summary of Product Characteristics https:\/\/ec.europa.eu\/health\/documents\/community\u2010register\/2012\/20120319120870\/anx_120870_en.pdf."},{"issue":"3","key":"e_1_2_9_45_1","first-page":"198","article-title":"Clinical Laboratory Monitoring of a Synthetic Antithrombin Agent, Argatroban, Using High Performance Liquid Chromatography and Functional Methods","volume":"18","author":"Ahmad S.","year":"1999","journal-title":"International Angiology"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqac131"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2025.11.015"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2020.20210"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1p274"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annfar.2014.06.006"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054\u2010015\u20101109\u20100"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24344"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11239\u2010005\u20100942\u20104"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19180"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615601"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13757"},{"key":"e_1_2_9_57_1","unstructured":"British Society of Haematology.Expert haematology Panel (EHP 2021) guidance\u2010version\u201013\u2010on\u2010mngmt\u2010of\u2010thrombosis\u2010with\u2010thrombocytopenia\u2010occurring\u2010after\u2010c\u201019\u2010vaccine_20210407.pdf(b\u2010s\u2010h.org.uk)."},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12844"}],"container-title":["International Journal of Laboratory Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijlh.70103","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ijlh.70103","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijlh.70103","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T03:27:51Z","timestamp":1783913271000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijlh.70103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1111\/ijlh.70103"],"URL":"https:\/\/doi.org\/10.1111\/ijlh.70103","archive":["Portico"],"relation":{},"ISSN":["1751-5521","1751-553X"],"issn-type":[{"value":"1751-5521","type":"print"},{"value":"1751-553X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"2025-12-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}